Blue Surface

Multi-modal Artificial Intelligence Platform for instant diagnostics, personalised prognostics and general health risk assessments, using retinal images

What is THEIA

THEIA is a unique set of AI engines, each specialised in using a different imaging modality for diagnostics, prognostics or health assessment purposes. THEIA can integrate with any existing patient health record management system, and is device \ clinic \ clinician agnostic

GPs, Ophthalmologist, Optometrists, Diabetologists and Cardiologists will all benefit from THEIA's vast capabilities

Who Is It For

Each capability of THEIA is clinically validated retrospectively and prospectively. THEIA is validated locally, when entering a new market.

Clinically Validated
What We Can Diagnose
  • Diagnose most common causes of vision loss including

    • Diabetic Retinopathy

    • Macular Degeneration

    • Glaucoma

    • Cataract

    • Detect cardiovascular risk factors that manifest in the eye

    • Hypertension

    • Diabetes

    • Hyperlipidemia

    • Chronic kidney disease retinopathy

  • Create personalised prognostic reports for  

    • Vision loss

    • Cardiovascular event

Eliminate preventable health and vision deterioration

  • Fast and accurate diagnosis heart and eye diseases that are manifested in the retina

  • Prognosis of disease onset and progression rate, based on individualised risk factors and longitudinal AI inferences

  • Compatible with all major retinal imaging modalities and devices

  • Accessible in variety of outlets to remove barriers to access healthcare

Our Vision


  • Cloud based , clinic, clinician and camera agnostic


  • Improved access to diagnosis and faster referral for treatment and personalised treatment plan


  • Accurate and efficient outcomes at a reasonable cost


  • Added service revenue module – increased patient throughput – opportunity gained. Appropriate referrals and fewer mundane tasks


  • An established platform for fast research outputs

Toku Eyes